2020
DOI: 10.1016/j.biomaterials.2020.120094
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR interference-mediated noggin knockdown promotes BMP2-induced osteogenesis and calvarial bone healing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 34 publications
(24 citation statements)
references
References 66 publications
0
22
0
Order By: Relevance
“…In addition, we demonstrated the nuclear expression of RUNX2 through PASI-stimulated BMP2 and Wnt3a signaling using Noggin and PKF. Noggin interacts with and antagonizes the action of BMP2 [49]. PKF disrupts β-catenin-TCF and inhibits β-catenin-regulated transcription activity [50,51].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, we demonstrated the nuclear expression of RUNX2 through PASI-stimulated BMP2 and Wnt3a signaling using Noggin and PKF. Noggin interacts with and antagonizes the action of BMP2 [49]. PKF disrupts β-catenin-TCF and inhibits β-catenin-regulated transcription activity [50,51].…”
Section: Discussionmentioning
confidence: 99%
“…Noggin knockdown led to increased BMP-2 activity within the cranial defects, which accelerated the repair of the lesion compared with defects that received cells transduced with a vector carrying a control shRNA. A recent study explored simultaneous noggin suppression and BMP-2 overexpression in rat adipose-derived stem cells [153]. Cells were co-transduced with baculovirus vectors carrying a BMP-2 gene and a CRISPR interference system to target endogenous noggin and then implanted in rat cranial defects using gelatin as carrier.…”
Section: Cell-based Gene Therapy For Cranial Bone Regenerationmentioning
confidence: 99%
“…From the perspective of recombinant protein strategies, new technologies have emerged that are still in their infancy but have a high potential in bone regenerative medicine. Particularly noteworthy in this regard, a very recent report from Hsu et al [ 102 ] has exploited the fact that BMP2 is known to induce the expression of its antagonist noggin that self-restricts its bioactivity. Therefore, they proposed that a CRISPRi-based system providing noggin inhibition concurrently to BMP2 overexpression might improve bone healing.…”
Section: Future Perspectivesmentioning
confidence: 99%